- 全部删除
您的购物车当前为空
Zalifrelimab (AGEN1884) 是一种靶向 CTLA-4(CTLA-4) 的全人 IgG1单克隆抗体。Zalifrelimab 拮抗受 CTLA-4信号调节的免疫细胞激活的抑制性检查点。
Zalifrelimab (AGEN1884) 是一种靶向 CTLA-4(CTLA-4) 的全人 IgG1单克隆抗体。Zalifrelimab 拮抗受 CTLA-4信号调节的免疫细胞激活的抑制性检查点。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 2,490 | 2-4周 | |
| 5 mg | ¥ 6,470 | 2-4周 | |
| 10 mg | ¥ 9,870 | 2-4周 |
Zalifrelimab 相关产品
| 产品描述 | Zalifrelimab (AGEN1884) is a fully human IgG1 monoclonal antibody that targets CTLA-4 (CTLA-4), functioning by antagonizing the CTLA-4-signaling-regulated inhibitory checkpoints of immune cell activation. |
| CAS No. | 2148321-69-9 |
| 存储 | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容